You Are Here: Home > About Arthritis > Arthritis in the News


    Apply Filters Clear All
    supplement news article

    May 06

    Discovery Pod speaks to Arthritis Society president and CEO Trish Barbato Arthritis Society president and CEO Trish Barbato talks with the Discovery Pod about joining the organization just before the COVID-19 pandemic, the challenges facing charities in the face of a global shutdown, and how innovation will play a key role as the organization evolves to meet the... Public
    supplement news article

    Apr 27

    COVID-19 (Coronavirus) We know people living with arthritis have a lot of questions about COVID-19 and arthritis. We’ve put together a list of common questions with answers below, as well as links to other resources. In addition to this Q&A, we've also hosted a series of special Arthritis Talks to... Arthritis Society
    supplement news article

    Apr 17

    COVID-19: Canada secures order for 5 million pills of hydroxychloroquine Feds secure drug supply of hydroxychloroquine for people with rheumatoid arthritis or lupus, in repsonse to advocacy from the Arthritis Society, rheumatologists and other stakeholders. National Post
    supplement news article

    Apr 15

    Coronavirus: The risks to essential workers with hidden health conditions Dr. Arif Jetha from the Institute of Work and Health examines the impact of COVID-19 on workers with hidden health conditions. Our chief science officer, Dr. Sian Bevan, comments on the concerns expressed by people with arthritis. Dr. Jetha's work is partly funded by an Arthritis Society... The Conversation
    supplement news article

    Apr 14

    Society’s adapting To isolation. As a disabled person, I hope the changes stick. In this powerful perspective piece, Mari "Dev" Ramsawakh, who lives with a chronic pain and fatigue from a disability, writes about how COVID-19 has suddenly made accessibility everybody's priority. People with arthritis can identify.   Public
    supplement news article

    Apr 10

    We don’t know yet if hydroxychloroquine can treat COVID-19, and Trump’s claims otherwise are dangerous U.S. President Donald Trump has been touting the drug hydroxychloroquine with all the subtlety of a carnival barker, creating shortages for people who rely on it to treat their arthritis. But neither treatment nor prevention is supported by evidence yet. (The Arthritis Society is funding research... The Globe and Mail
    supplement news article

    Apr 02

    Canadian lupus patients missing critical drug after claims it treats coronavirus Chloroquine and hydroxychloroquine supplies are low due to coronavirus, causing concern for patients who rely on the drugs to treat conditions like lupus and rheumatoid arthritis. The Arthritis Society is working with governments to limit the extent to which arthritis patient care impacted by... Public
    supplement news article

    Mar 30

    Arthritis and Lupus patients running low on meds due to misinformation about COVID-19 Our Chief Science Officer, Dr. Sian Bevan, and arthritis ambassador Darlene McPherson, comment on how COVID-19 has led to a shortage of Hydroxychloroquine – a drug used to treat Rheumatoid Arthritis and Lupus – and how it's impacting patients. The Arthritis Society continues to... CTV News
    supplement news article

    Mar 26

    Global Rheumatology Alliance - Patient Experience survey The COVID-19 (Novel coronavirus) pandemic has quickly infected over a million people worldwide.  While most people with COVID-19 infections have mild or no symptoms, a significant proportion of patients can become quite ill. At this time, little is known about how patients with rheumatic... Public
     |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 
    Load More